Meta-Analysis: Botulinum A Tops Placebo for Chronic Migraine
Frequency of chronic migraines significantly reduced after three months; QoL improved
Rituximab Beneficial in Secondary Progressive MS
Treatment with rituximab linked to lower Expanded Disability Status Scale score, delayed progression
Sex Differences ID’d in Response to Glioblastoma Treatment
Standard therapy more effective for female versus male patients with glioblastoma
Risk for MCI Up With Progressive Cerebral Small Vessel Disease
Patients with hypertension with progressive cSVD have increased risk for mild cognitive impairment
Prenatal Valproate Exposure Linked to Increased ADHD Risk
Maternal use of other antiepileptic drugs not tied to increased ADHD risk
Artificial Intelligence Can Detect, Classify Acute Brain Bleeds
Further, the system can justify its decisions using an atlas of training CT images
Clinical Tool Rapidly Assesses Post-Intensive Care Syndrome
27-item questionnaire found to be valid clinical tool for assessing PICS
December 2018 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for December 2018. This roundup includes the latest...
Impaired Cognitive Status Impacts Rehab Potential in SNFs
Older adults with cognitive impairment admitted to skilled nursing facilities make fewer gains
Higher Risk for Depression, Anxiety Seen With Cerebral Palsy
Association seen in patients with cerebral palsy without accompanying intellectual disability
